CureVac NV (CVAC)
2.64
+0.12
(+4.76%)
USD |
NASDAQ |
May 01, 16:00
2.64
0.00 (0.00%)
After-Hours: 20:00
CureVac Price to Book Value: 1.036 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 1.036 |
| April 30, 2024 | 0.9892 |
| April 29, 2024 | 0.9892 |
| April 26, 2024 | 0.9146 |
| April 25, 2024 | 0.9068 |
| April 24, 2024 | 0.9853 |
| April 23, 2024 | 1.021 |
| April 22, 2024 | 0.9931 |
| April 19, 2024 | 0.9578 |
| April 18, 2024 | 0.9578 |
| April 17, 2024 | 1.009 |
| April 16, 2024 | 1.046 |
| April 15, 2024 | 1.040 |
| April 12, 2024 | 1.142 |
| April 11, 2024 | 1.162 |
| April 10, 2024 | 1.158 |
| April 09, 2024 | 1.166 |
| April 08, 2024 | 1.205 |
| April 05, 2024 | 1.201 |
| April 04, 2024 | 1.162 |
| April 03, 2024 | 1.142 |
| April 02, 2024 | 1.130 |
| April 01, 2024 | 1.170 |
| March 28, 2024 | 1.189 |
| March 27, 2024 | 1.197 |
| Date | Value |
|---|---|
| March 26, 2024 | 1.154 |
| March 25, 2024 | 1.236 |
| March 22, 2024 | 1.197 |
| March 21, 2024 | 1.193 |
| March 20, 2024 | 1.197 |
| March 19, 2024 | 1.154 |
| March 18, 2024 | 1.26 |
| March 15, 2024 | 1.295 |
| March 14, 2024 | 1.305 |
| March 13, 2024 | 1.321 |
| March 12, 2024 | 1.337 |
| March 11, 2024 | 1.317 |
| March 08, 2024 | 1.344 |
| March 07, 2024 | 1.305 |
| March 06, 2024 | 1.286 |
| March 05, 2024 | 1.305 |
| March 04, 2024 | 1.321 |
| March 01, 2024 | 1.341 |
| February 29, 2024 | 1.341 |
| February 28, 2024 | 1.376 |
| February 27, 2024 | 1.403 |
| February 26, 2024 | 1.341 |
| February 23, 2024 | 1.294 |
| February 22, 2024 | 1.325 |
| February 21, 2024 | 1.341 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9068
Minimum
Apr 25 2024
27.50
Maximum
Dec 09 2020
7.299
Average
3.813
Median
Price to Book Value Benchmarks
| Affimed NV | 1.270 |
| InflaRx NV | 0.7322 |
| MorphoSys AG | 48.72 |
| BioNTech SE | 0.9686 |
| Immatics NV | 4.474 |
Price to Book Value Related Metrics
| PS Ratio | 10.02 |
| Price | 2.64 |
| Earnings Yield | -48.36% |
| Market Cap | 592.17M |